RABEPRAZOL TEVA-RATIO 10 mg GASTRO-RESISTANT TABLETS

2. What you need to know before you take Rabeprazol Teva-ratio

Do not take Rabeprazol Teva-ratio

• if you are allergic (hypersensitive) to rabeprazol sodium, or any of the other ingredients of this medicine (listed in section 6).
• If you are pregnant or think you may be pregnant.
• If you are breast-feeding.

Do not take Rabeprazol Teva-ratio if any of the above apply to you. If you are not sure, consult your doctor or pharmacist before taking Rabeprazol Teva-ratio.

See also the section on Pregnancy and breast-feeding.

Children

Rabeprazol Teva-ratio should not be used in children.

Warnings and precautions

Consult your doctor or pharmacist before starting treatment with Rabeprazol Teva-ratio:

• If you are allergic to proton pump inhibitors or “substituted benzimidazoles”.
• If liver or blood problems have been seen in some patients but usually get better when treatment with Rabeprazol Teva-ratio is stopped.
• If you have a stomach tumor.
• If you have ever had liver problems.
• If you are taking atazanavir, a medicine for HIV infection.
• If you have reduced body stores or risk factors for low vitamin B12 and are taking long-term treatment with rabeprazol sodium. As with all acid-reducing agents, rabeprazol sodium may lead to a reduced absorption of vitamin B12.
• If you are due to have a specific blood test (Chromogranin A)
• If you have ever had a skin reaction with a medicine that reduces stomach acid.

If you get a rash, especially in areas of skin exposed to the sun, tell your doctor as soon as possible, as you may need to stop treatment with Rabeprazol Teva-ratio. Also remember to mention any other symptoms you might notice, such as joint pain.

If you are in doubt about any of the above, consult your doctor or pharmacist before taking Rabeprazol Teva-ratio.

Your doctor may have carried out a diagnostic test called endoscopy to diagnose your condition and/or exclude malignant disease. Before starting treatment, it is necessary to exclude the possibility of stomach or oesophageal cancer.

If you experience severe diarrhea with blood and mucus, fever, abdominal pain or tenderness, stop taking Rabeprazol Teva-ratio and consult your doctor immediately.

During treatment with rabeprazol, kidney inflammation can occur. Signs and symptoms include: decreased urine output or blood in the urine and/or hypersensitivity reactions such as fever, rash, and joint stiffness. You should inform your doctor of these signs.

If you are taking proton pump inhibitors like rabeprazol, especially over a period of more than one year, you may have a slightly increased risk of fractures of the hip, wrist, and spine. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).

If you take this medicine for a long time (more than one year), your doctor will probably keep you under regular surveillance. When you attend a follow-up visit, you should inform your doctor of any new or different symptoms.

Other medicines and Rabeprazol Teva-ratio

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription, including herbal medicines.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines:

• Ketoconazole or itraconazole, medicines for fungal infections. Rabeprazol Teva-ratio may decrease the amount of these medicines in the blood. Your doctor may need to adjust the dose.
• Atazanavir, a medicine used to treat HIV infection. Rabeprazol Teva-ratio may decrease the amount of this type of medicine in the blood, so they should not be used together.
• Methotrexate (a chemotherapy medicine used at high doses to treat cancer) – if you are taking a high dose of methotrexate, your doctor may temporarily stop your treatment with rabeprazol.

If you are in doubt about any of the above, consult your doctor or pharmacist before taking Rabeprazol Teva-ratio.

Pregnancy and breast-feeding

• Do not take Rabeprazol Teva-ratio if you are pregnant or if you think you may be pregnant.
• Do not take Rabeprazol Teva-ratio during breast-feeding or if you plan to start breast-feeding.

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

You may feel drowsy while taking this medicine. If this happens, do not drive or use tools or machines.

Rabeprazol Teva-ratio contains lactose

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Rabeprazol Teva-ratio contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per gastro-resistant tablet; this is essentially “sodium-free”.

3. How to take Rabeprazol Teva-ratio

Follow the instructions for administration of this medicine exactly as told by your doctor. Ask your doctor or pharmacist if you are unsure.

Taking this medicine

• Only remove a tablet from the blister when it is time to take your medicine.
• Swallow the tablet whole with a little water. Do not chew or crush the tablet.
• Your doctor will tell you the number of tablets to take and the length of your treatment, which will depend on your condition.
• If you are taking this medicine for a long time, your doctor will want to monitor you.

Adults and elderly patients

For “gastro-oesophageal reflux disease” (GORD)

Treatment of moderate to severe symptoms (symptomatic GORD)

• The recommended dose is one Rabeprazol Teva-ratio 10 mg tablet once a day for up to 4 weeks.
• Take the tablet in the morning before eating.
• If your symptoms come back after 4 weeks of treatment, your doctor will tell you to take one Rabeprazol Teva-ratio 10 mg tablet when you need it.

Treatment of more severe symptoms (erosive or ulcerative GORD)

• The recommended dose is one Rabeprazol Teva-ratio 20 mg tablet once a day for 4 to 8 weeks.
• Take the tablet in the morning before eating.

Long-term treatment of symptoms (GORD maintenance)

• The recommended dose is one Rabeprazol Teva-ratio 10 mg or 20 mg tablet once a day for as long as your doctor has told you.
• Take the tablet in the morning before eating.
• Your doctor will want to see you at regular intervals to check your symptoms and dose.

For stomach ulcers (peptic ulcers)

• The recommended dose is one Rabeprazol Teva-ratio 20 mg tablet once a day for 6 weeks.
• Take the tablet in the morning before eating.
• Your doctor may tell you to take Rabeprazol Teva-ratio for another 6 weeks if your symptoms do not improve.

For duodenal ulcers

• The recommended dose is one Rabeprazol Teva-ratio 20 mg tablet once a day for 4 weeks.
• Take the tablet in the morning before eating.
• Your doctor may tell you to take Rabeprazol Teva-ratio for another 4 weeks if your symptoms do not improve.

For ulcers caused by H. pylori infection and to prevent recurrence

• The recommended dose is one Rabeprazol Teva-ratio 20 mg tablet twice a day for 7 days.
• Your doctor will also tell you to take antibiotics called amoxicillin and clarithromycin.

For more information on the other medicines used to treat H. pylori, read the package leaflet for each of them.

Zollinger-Ellison syndrome where there is too much acid in the stomach

• The recommended dose is three Rabeprazol Teva-ratio 20 mg tablets once a day to start with.
• The dose may be adjusted by your doctor depending on how you respond to treatment.

If you are on long-term treatment, you will need to see your doctor at regular intervals for a review of your dose and symptoms.

Use in children

This medicine should not be used in children.

Patients with liver problems

Consult your doctor, who will take special care when starting and during treatment with this medicine.

If you take more Rabeprazol Teva-ratio than you should

If you take more Rabeprazol Teva-ratio than you should, talk to your doctor or go to a hospital immediately. Take the medicine with you.

In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, telephone 91-562 04 20, indicating the medicine and the amount taken.

If you forget to take Rabeprazol Teva-ratio

• If you forget to take a tablet, take one as soon as you remember and then continue as usual. However, if it is almost time for your next tablet, skip the missed tablet and continue as usual.
• If you forget to take your medicine for more than 5 days, consult your doctor before taking any more medicine.
• Do not take a double dose (two doses at the same time) to make up for a forgotten dose.

If you stop taking Rabeprazol Teva-ratio

Relief of symptoms normally occurs before the ulcer is completely healed. It is important that you do not stop treatment until your doctor tells you to.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, Rabeprazol Teva-ratio can cause side effects, although not everybody gets them. Side effects are usually mild and improve without you having to stop taking the medicine.

Stop taking Rabeprazol Teva-ratio and see your doctor immediately if you notice any of the following serious side effects - you may need urgent medical treatment:

• Allergic reactions - the signs may include: sudden swelling of your face, difficulty breathing or low blood pressure which may cause dizziness or fainting.
• Frequent infections, such as sore throat or high temperature (fever), or ulcers in your mouth or throat.
• Bruising or easy bleeding.
• Yellowing of the skin or whites of the eyes (jaundice), dark urine, and tiredness, which can be signs of liver problems.

These side effects are rare (may affect up to 1 in 1,000 people).

• Severe skin blistering or peeling, or mouth ulcers.

These side effects are very rare (may affect up to 1 in 10,000 people).

Other possible side effects:

Common (may affect up to 1 in 10 people)

• Infections.
• Difficulty sleeping.
• Headache or dizziness.
• Cough, runny nose, or sore throat (pharyngitis).
• Effects on your stomach or intestines such as stomach pain, diarrhea, gas (flatulence), feeling sick (nausea), being sick (vomiting), or constipation.
• Pain or back pain.
• Weakness or flu-like symptoms.
• Benign polyps in the stomach.

Uncommon (may affect up to 1 in 100 people)

• Feeling nervous or sleepy.
• Chest infection (bronchitis).
• Painful sinuses (sinusitis).
• Dry mouth.
• Indigestion or belching.
• Rash or redness of the skin.
• Muscle pain, leg pain, or joint pain.
• Fracture of the hip, wrist, or spine.
• Urinary tract infection (infection of the urine system).
• Chest pain.
• Chills or fever.
• Changes in liver function (shown in blood tests).

Rare (may affect up to 1 in 1,000 people)

• Lack of appetite (anorexia).
• Depression.
• Hypersensitivity (including allergic reactions).
• Vision problems.
• Inflamed mouth (stomatitis) or taste problems.
• Stomach problems or stomach pain.
• Liver problems, including yellowing of the skin and whites of the eyes (jaundice).
• Itchy rash or blisters.
• Sweating.
• Kidney problems.
• Weight increase.
• Changes in white blood cells (shown in blood tests) which can lead to frequent infections.
• Decrease in blood platelets which can lead to bleeding or bruising more easily than normal.
• Patient who have had previous liver problems may very rarely develop encephalopathy (brain disease).

Frequency not known (cannot be estimated from the available data)

• Swelling of the breasts in men.

• Fluid retention.
• Inflammation of the intestine (which can lead to diarrhea).
• Low levels of sodium in the blood which can cause tiredness and confusion, muscle spasms, convulsions, and coma.
• Skin rash, possibly with pain in the joints.

If you are taking rabeprazol for more than three months, it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can cause fatigue, muscle spasms, convulsions, dizziness, increased heart rate. If you have any of these symptoms, go to your doctor immediately. Low levels of magnesium can also lead to a decrease in the levels of potassium and calcium in the blood. Your doctor may decide to carry out regular blood tests to check the levels of magnesium.

Reporting of side effects:

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Rabeprazol Teva-ratio

Keep this medicine out of the sight and reach of children. Store below 25°C.

Store in the original package to protect from moisture.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month stated.

Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for disposal. If you are unsure, ask your pharmacist how to dispose of unused medicines. This will help protect the environment.

6. Container Content and Additional Information

Composition of Rabeprazol Teva-ratio

• The active ingredient is sodium rabeprazole.

Each gastro-resistant tablet contains 10 mg of sodium rabeprazole.

• The other components (excipients) are:

Core: Mannitol, low-substituted hydroxypropylcellulose, magnesium oxide, hydroxypropylcellulose, magnesium stearate.

Coating:

Hypromellose (E464), microcrystalline cellulose, stearic acid, titanium dioxide (E171), hypromellose phthalate, triethyl citrate, lactose monohydrate, macrogol 4000, red iron oxide (E172), yellow iron oxide (E172).

Printing ink:

Shellac, black iron oxide (E172), ammonium hydroxide, propylene glycol.

Appearance of the Product and Container Content:

Rabeprazol Teva-ratio 10 mg gastro-resistant tablets are pink, round tablets, printed on one side of the tablet with black ink "N" and "10".

Rabeprazol Teva-ratio is available in packs of 7, 14, 28, 30, 50, 56, and 98 gastro-resistant tablets.

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer:

Marketing Authorization Holder

Teva Pharma, S.L.U.

Anabel Segura 11, Edificio Albatros B 1st floor

28108 Alcobendas, Madrid (Spain)

Manufacturer

Pharmachemie B.V.

Swensweg 5,

2031 GA Haarlem, Netherlands

or

TEVA Pharmaceutical Works Private Limited Company

Pallagi út 13, 4042 Debrecen

Hungary

or

TEVA PHARMA, S.L.U.

C/ C, n° 4, Poligono Industrial Malpica,

Zaragoza, 50016

Spain

or

Teva Czech Industries s.r.o.

Ostravská 29, Opava-Komárov 74770

Czech Republic

or

Merckle GmbH

Ludwig-Merckle-Strasse 3,

89143 Blaubeuren-Weiler

Germany

or

Teva Operations Poland Sp. z.o.o,

ul. Mogilska 80, 31-546 Kraków,

Poland

Date of Last Revision of this Leaflet: October 2022

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/